Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (Newton [nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage]) - Hänggi, Daniel; Etminan, Nima; Steiger, Hans-Jakob; Mayer, Stephan A.; Macdonald, Robert Loch (Stroke, 2017)
Originally published December 8, 2016
Gesehen am 04.10.2018